Home Latest Videos CME Business of Medicine
Doc Life Doc Rant Doc Humor Dueling Doctors
Reuters Health • The Doctor's Channel Daily Newscast
 
Email:

Remember Me

Password:
Trouble Logging In?

Allergy & Clinical Immunology

Alternative Medicine

Anesthesiology

Business of Medicine

Cardiology

Critical Care

Dentistry

Dermatology

Diabetes & Endocrinology

Doc Humor

Doc Rant

Emergency Medicine

Family Medicine

Gastroenterology

Hematology-Oncology

HIV/AIDS

Hospitalist

Human Interest

Infectious Diseases

Internal Medicine

Medical Informatics

Medical Students

Nephrology

Neurology & Neurosurgery

Nurses/NP/PA

Ob/Gyn

Oncology

Ophthalmology

Orthopaedics

Otolaryngology

Pathology & Lab Medicine

Patient Education

Pediatrics

Pharma Film Festival

Pharmacists

Professional Development

Prostate Film Festival

Psychiatry & Mental Health

Public Health & Prevention

Pulmonary Medicine

Radiology

Reuters Health • The Doctor's Channel Daily Newscast

Rheumatology

Sexual Medicine

Sleep Medicine

Surgery

Transplantation

Travel Medicine

Understanding the Burden of Psoriasis

Urology

Veterinary Medicine

Video Job Finder

Women’s Health

 
  Critical Care
No drop in survival seen with smaller living donor liver grafts
Reuters Health • The Doctor's Channel Daily Newscast
Alternate HTML content should be placed here. This content requires the Macromedia Flash Player. Get Flash

 

Rating:  
0 ratings
Views: 2,232 Video Length: 01:41

More in

Critical Care

Gastroenterology

Internal Medicine

Medical Students

Pathology & Lab Medicine

Reuters Health • The Doctor's Channel Daily Newscast

Surgery

Transplantation

Posted: November 17, 2009
NEW YORK (Reuters Health) - In a study of living donor liver transplantations with left side grafts, no significant difference in survival was seen when grafts <35% of the recipient's standard liver volume (SLV) were used versus larger grafts. Being able to use smaller grafts can reduce the risks to the donor.

In a previous study, Dr. Shinichi Miyagawa and colleagues from Shinshu University School of Medicine, Matsumoto, Japan, had shown that a recipient's metabolic demands can be met using grafts as low as 30% of the recipient's SLV. In the current study, the team examined the impact of graft size on several clinical outcomes, including survival.

The study, reported in the November issue of Liver Transplantation, featured 120 adult recipients of left side liver grafts (either the left lobe alone, or the left lobe with the caudate lobe). Thirty-three received grafts <35% of their SLV and 87 received larger grafts. The recipient and donor characteristics for the two groups were comparable, except that mean pretransplant prothrombin time and INR were higher and mean body weight was greater in the group that received the relatively smaller grafts.

The average graft volume/recipient SLV ratio was 31.8% in the smaller graft group and 42.5% in the larger graft group, the report indicates.

Pretransplant Model for End-Stage Liver Disease (MELD) scores were similar in the two groups, as were postoperative serum total bilirubin levels, prothrombin time, INR, and hospital stay, the report indicates. Likewise, the 1-year patient and graft survival rates in the smaller and larger graft groups were not significantly different (80.7% vs. 90.8%), nor were the 5-year survival rates (64.2% vs. 84.9%).

The rate of small-for-size graft syndrome, which is defined by various parameters of graft dysfunction, was "very low" and similar for each group.

Seven deaths were logged from 1 to 5 years posttransplantation and the causes included stroke, recurrent liver cancer, uterine cancer, and sepsis. "These deaths," co-author Dr. Toshihiko Ikegami said in a statement, "occurred in patients with good liver function who had resumed their normal lives. The causes of death were not related to insufficient graft size."

Although the study did not include right lobe grafts, based on their own experience and that of others, the authors believe that left side grafts are preferable.

"We feel that left side grafts should be used more frequently in adult-to-adult living donor liver transplantation because of the lower risk to donors in comparison with right lobe grafts."

Reference:
Liver Transpl 2009;15:1622-1630.
Comments & Responses
 
Would you like to comment?
Join The Doctor's Channel for a free account, or Login if you are already a member.
Videos in Critical Care

In diabetics, revascularization more likely after PCI vs ...

186 Views

DVT predicts death in patients with pulmonary embolism

134 Views

Single ultrasound test may suffice to rule out DVT

1234 Views

Platelet rebound not seen after clopidogrel cessation

1146 Views

Short-term outcomes same for CABG with and without bypass

1073 Views

Early anticoagulation may improve survival after pulmonar...

860 Views

Nifekalant tops lidocaine for shock-resistant ventricular...

5535 Views

Intensive insulin therapy does not improve septic shock m...

522 Views

Angiography confirms efficacy of lower-dose alteplase for...

351 Views

CABG operative mortality higher in women than in men

1295 Views

Catheter ablation beats drug therapy for refractory atria...

634 Views

Treating subclinical neonatal seizures may prevent brain ...

585 Views

Atorvastatin does not prevent contrast nephropathy in kid...

990 Views

Biomarker-guided treatment of infection reduces antibioti...

1320 Views

Endovascular treatment usually effective for very small b...

319 Views

Early beta-blockade for ACS does not alter short-term mor...

684 Views

Embed